+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cancer Vaccines Market - Global Forecast 2025-2030- Product Image
Cancer Vaccines Market - Global Forecast 2025-2030- Product Image
Sale

Cancer Vaccines Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6010630
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cancer vaccines market is rapidly evolving as immunotherapy transforms oncology. Senior leaders across the biopharmaceutical supply chain are closely monitoring how emerging vaccine platforms, regulatory shifts, and supply chain dynamics are shaping new standards of cancer care.

Market Snapshot: Cancer Vaccines Market Growth and Trends

The Cancer Vaccines Market grew from USD 7.11 billion in 2024 to USD 7.78 billion in 2025. It is expected to continue growing at a CAGR of 9.60%, reaching USD 12.33 billion by 2030.

Scope & Segmentation of the Cancer Vaccines Market

This report offers actionable insights into the full value chain, highlighting market segmentation and technology trends influencing development and adoption:

  • Product Types: Preventive cancer vaccines and therapeutic cancer vaccines.
  • Formulations: Cell-based vaccines, nucleic acid-based vaccines (DNA and RNA), peptide/protein-based vaccines, synthetic vaccines, viral vector-based vaccines.
  • Administration Pathways: Intramuscular and intravenous delivery.
  • Development Phases: Clinical trials, Phase I, Phase II, Phase III asset stages.
  • Indications: Breast, colorectal, lung, melanoma, and prostate cancers.
  • End-Users: Cancer research institutes, hospitals and clinics, specialty treatment centers.
  • Regional Coverage: Americas (including United States—California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio—Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (UK, Germany, France, Russia, Italy, Spain, UAE, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan).
  • Key Companies Profiled: Industry leaders such as Amgen, Bayer, AstraZeneca, BioNTech, Moderna, Pfizer, Sanofi, Johnson & Johnson, GSK, and others are analyzed for recent advancements and competitive moves.

The Critical Role of Cancer Vaccines

Cancer vaccines are redefining oncology by using immune-based approaches for both prevention and treatment. Their dual role allows stakeholders to address both prophylactic needs and active malignancy management, driving comprehensive change across industry, clinical settings, and research consortia.

Key Takeaways for Senior Decision-Makers

  • Rapid innovation is accelerating cancer vaccine adoption, driven by advancements in mRNA, viral vectors, and synthetic nanoparticle delivery technologies.
  • Next-generation vaccines support personalized treatment, leveraging antigen selection strategies matched to specific tumor types.
  • Integrative collaborations between biopharma companies, academic centers, and manufacturing organizations facilitate faster clinical translation and scale-up.
  • Regulatory agencies are adopting adaptive trial designs and expedited review pathways, increasing the speed from proof-of-concept to advanced clinical evaluation.
  • Regional manufacturing partnerships and localized supply chain frameworks enhance agility in response to market and policy changes.

Tariff Impact: Navigating New US Tariffs on Biologics and Adjuvants

Recent US tariffs on imported biologics and adjuvants are introducing new complexities in cancer vaccine supply chains. Companies reliant on specialty components are reassessing sourcing strategies and exploring domestic manufacturing and vertical integration. These shifts influence production timelines and investment decision-making. Regional partners and contract development organizations in tariff-exempt locations are gaining significance as supply chain resilience becomes a priority.

Methodology & Data Sources

This report is based on a mixed-method approach, combining primary expert interviews with senior immunologists, oncologists, regulatory affairs professionals, and biomanufacturing executives. Secondary sources include peer-reviewed research, patents, whitepapers, and official regulatory guidance. Robust cross-validation and opinion leader consultation strengthen the accuracy and relevance of all findings.

Cancer Vaccines Market: Why This Report Matters

  • Equip your strategic planning with precise segmentation intelligence and market dynamics supporting investment and partnership decisions.
  • Understand regulatory shifts, technological advancements, and region-specific drivers impacting commercialization and operational risk mitigation.
  • Leverage actionable recommendations for accelerating clinical development, fostering collaborations, and ensuring competitive market positioning.

Conclusion

As cancer vaccine technologies mature, strategic alignment across innovation, supply chain, and regulatory practice will define success in this market. Staying ahead demands both agility and insight as the oncology landscape continues its transformation.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising use of artificial intelligence in identifying novel cancer vaccine targets and optimizing formulations
5.2. Growing investment in neoantigen-based cancer vaccines fueling precision oncology benefits
5.3. Utilization of AI and machine learning for optimizing cancer vaccine design and patient selection
5.4. Development of multi-epitope vaccines designed to elicit broader immune responses against cancer
5.5. Innovations in delivery systems for cancer vaccines increasing efficacy and patient compliance
5.6. Supportive regulatory approvals fueling the commercialization of innovative cancer vaccines
5.7. Expansion of preventive cancer vaccines targeting virus-associated cancers
5.8. Advancements in personalized cancer vaccines leveraging neoantigen targeting enhancing immune response
5.9. Rising collaboration among biotech firms accelerating cancer vaccine research and development
5.10. Expansion of prophylactic cancer vaccines aiming to prevent virus-associated malignancies
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cancer Vaccines Market, by Product Type
8.1. Introduction
8.2. Preventive Cancer Vaccines
8.3. Therapeutic Cancer Vaccines
9. Cancer Vaccines Market, by Formulations
9.1. Introduction
9.2. Cell-Based Vaccines
9.2.1. Dendritic Cell Vaccines
9.2.2. Tumor Cell Vaccines
9.3. Nucleic Acid-Based Vaccines
9.3.1. DNA Vaccines
9.3.2. RNA Vaccines
9.4. Peptide/Protein-Based Vaccines
9.5. Synthetic Vaccines
9.6. Viral Vector-Based Vaccines
10. Cancer Vaccines Market, by Administration Pathway
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
11. Cancer Vaccines Market, by Development Phase
11.1. Introduction
11.2. Clinical Trials
11.3. Phase I
11.4. Phase II
11.5. Phase III
12. Cancer Vaccines Market, by Indication
12.1. Introduction
12.2. Breast Cancer
12.3. Colorectal Cancer
12.4. Lung Cancer
12.5. Melanoma
12.6. Prostate Cancer
13. Cancer Vaccines Market, by End-User
13.1. Introduction
13.2. Cancer Research Institutes
13.3. Hospitals & Clinics
13.4. Specialty Cancer Treatment Centers
14. Americas Cancer Vaccines Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cancer Vaccines Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cancer Vaccines Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Amgen Inc.
17.3.2. Bayer AG
17.3.3. Advaxis Inc.
17.3.4. AstraZeneca PLC
17.3.5. BioNTech SE
17.3.6. Bristol Myers Squibb Company
17.3.7. Celldex Therapeutics, Inc.
17.3.8. CureVac SE
17.3.9. Dynavax Technologies Corporation
17.3.10. Eli Lilly and Company
17.3.11. F. Hoffmann-La Roche AG
17.3.12. GSK PLC
17.3.13. Helsinn Healthcare SA
17.3.14. Inovio Pharmaceuticals, Inc.
17.3.15. Johnson & Johnson Services, Inc
17.3.16. JW CreaGene
17.3.17. Merck & Co., Inc.
17.3.18. Moderna, Inc.
17.3.19. Pfizer Inc.
17.3.20. Sanofi SA
17.3.21. Sanpower Group Co., Ltd.
17.3.22. Scorpius Holdings, Inc.
17.3.23. Serum Institute of India Pvt. Ltd.
17.3.24. Sun Pharmaceutical Industries Ltd.
17.3.25. Vaxine Pty Ltd
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CANCER VACCINES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CANCER VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CANCER VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CANCER VACCINES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CANCER VACCINES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CANCER VACCINES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CANCER VACCINES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CANCER VACCINES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CANCER VACCINES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. CANCER VACCINES MARKET: RESEARCHAI
FIGURE 28. CANCER VACCINES MARKET: RESEARCHSTATISTICS
FIGURE 29. CANCER VACCINES MARKET: RESEARCHCONTACTS
FIGURE 30. CANCER VACCINES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CANCER VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CANCER VACCINES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CANCER VACCINES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CANCER VACCINES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CANCER VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CANCER VACCINES MARKET SIZE, BY PREVENTIVE CANCER VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CANCER VACCINES MARKET SIZE, BY PREVENTIVE CANCER VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CANCER VACCINES MARKET SIZE, BY THERAPEUTIC CANCER VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CANCER VACCINES MARKET SIZE, BY THERAPEUTIC CANCER VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CANCER VACCINES MARKET SIZE, BY DENDRITIC CELL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CANCER VACCINES MARKET SIZE, BY DENDRITIC CELL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CANCER VACCINES MARKET SIZE, BY TUMOR CELL VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CANCER VACCINES MARKET SIZE, BY TUMOR CELL VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CANCER VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CANCER VACCINES MARKET SIZE, BY DNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CANCER VACCINES MARKET SIZE, BY RNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CANCER VACCINES MARKET SIZE, BY RNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CANCER VACCINES MARKET SIZE, BY PEPTIDE/PROTEIN-BASED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CANCER VACCINES MARKET SIZE, BY PEPTIDE/PROTEIN-BASED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CANCER VACCINES MARKET SIZE, BY SYNTHETIC VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CANCER VACCINES MARKET SIZE, BY SYNTHETIC VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CANCER VACCINES MARKET SIZE, BY VIRAL VECTOR-BASED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CANCER VACCINES MARKET SIZE, BY VIRAL VECTOR-BASED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CANCER VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CANCER VACCINES MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CANCER VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CANCER VACCINES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CANCER VACCINES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CANCER VACCINES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CANCER VACCINES MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CANCER VACCINES MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CANCER VACCINES MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CANCER VACCINES MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CANCER VACCINES MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CANCER VACCINES MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CANCER VACCINES MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CANCER VACCINES MARKET SIZE, BY MELANOMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CANCER VACCINES MARKET SIZE, BY MELANOMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CANCER VACCINES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CANCER VACCINES MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CANCER VACCINES MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CANCER VACCINES MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CANCER VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CANCER VACCINES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CANCER VACCINES MARKET SIZE, BY SPECIALTY CANCER TREATMENT CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CANCER VACCINES MARKET SIZE, BY SPECIALTY CANCER TREATMENT CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CANCER VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CANCER VACCINES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 114. CANADA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 115. CANADA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 116. CANADA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 117. CANADA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 118. CANADA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 119. CANADA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 120. CANADA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 121. CANADA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 122. CANADA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 123. CANADA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. CANADA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CANCER VACCINES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 257. ITALY CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 260. ITALY CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 261. ITALY CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 262. ITALY CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 263. ITALY CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 264. ITALY CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 265. ITALY CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 266. ITALY CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 267. ITALY CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 268. ITALY CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 269. ITALY CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. ITALY CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. ITALY CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 272. ITALY CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 279. SPAIN CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 280. SPAIN CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 282. SPAIN CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 283. SPAIN CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 284. SPAIN CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 285. SPAIN CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. SPAIN CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. SPAIN CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 288. SPAIN CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 289. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 290. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 291. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 292. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 293. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 294. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 295. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 296. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 297. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 298. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 299. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 300. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 301. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 305. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 306. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 307. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 308. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 309. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 310. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 312. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 314. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 316. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 318. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 319. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 320. SAUDI ARABIA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 322. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 324. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 326. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 327. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2018-2024 (USD MILLION)
TABLE 328. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY NUCLEIC ACID-BASED VACCINES, 2025-2030 (USD MILLION)
TABLE 329. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2018-2024 (USD MILLION)
TABLE 330. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY ADMINISTRATION PATHWAY, 2025-2030 (USD MILLION)
TABLE 331. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2018-2024 (USD MILLION)
TABLE 332. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY DEVELOPMENT PHASE, 2025-2030 (USD MILLION)
TABLE 333. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 334. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 335. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 336. SOUTH AFRICA CANCER VACCINES MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 337. DENMARK CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 338. DENMARK CANCER VACCINES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 339. DENMARK CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2018-2024 (USD MILLION)
TABLE 340. DENMARK CANCER VACCINES MARKET SIZE, BY FORMULATIONS, 2025-2030 (USD MILLION)
TABLE 341. DENMARK CANCER VACCINES MARKET SIZE, BY CELL-BASED VACCINES

Samples

Loading
LOADING...

Companies Mentioned

  • Amgen Inc.
  • Bayer AG
  • Advaxis Inc.
  • AstraZeneca PLC
  • BioNTech SE
  • Bristol Myers Squibb Company
  • Celldex Therapeutics, Inc.
  • CureVac SE
  • Dynavax Technologies Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GSK PLC
  • Helsinn Healthcare SA
  • Inovio Pharmaceuticals, Inc.
  • Johnson & Johnson Services, Inc
  • JW CreaGene
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Pfizer Inc.
  • Sanofi SA
  • Sanpower Group Co., Ltd.
  • Scorpius Holdings, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Vaxine Pty Ltd

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.78 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.33 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cancer Vaccines Market by Type, Technology, Indication, ROA, End User - Global Forecast to 2032 - Product Image

Cancer Vaccines Market by Type, Technology, Indication, ROA, End User - Global Forecast to 2032

  • Report
  • 263 Pages
  • Global
From
US cancer vaccine industry outlook to 2028 - Product Image

US cancer vaccine industry outlook to 2028

  • Report
  • 85 Pages
  • United States
From
Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Cancer Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 187 Pages
  • Global
From
Dendritic Cell Cancer Vaccine Market - Global Forecast 2025-2030 - Product Image

Dendritic Cell Cancer Vaccine Market - Global Forecast 2025-2030

  • Report
  • 192 Pages
  • Global
From
Peptide Vaccine for Tumor Market - Global Forecast 2025-2030 - Product Image

Peptide Vaccine for Tumor Market - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.